secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001193125-25-244191
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q3 revenue $50.1B (+12% YoY), GAAP EPS $5.32, adj. EPS $6.03; FY guidance reaffirmed
--------------------------------------------------------------------------------

- Health Benefits operating revenue $42.2B (+10% YoY), operating margin 1.4%, medical membership ~45.4M.
- Carelon revenue $18.3B (+33% YoY), operating margin 4.2%; driven by acquisitions and pharmacy growth.
- Benefit expense ratio 91.3% (up 180 bps YoY) on elevated Medicare Part D trend; operating expense ratio improved 130 bps to 10.5%.
- Year-to-date operating cash flow $4.2B; Q3 share repurchases 2.9M shares at $303.48 avg price, $875M total.
- Dividend of $1.71/share declared, payable Dec 19, 2025 to holders of record Dec 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/0001193125-25-244191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312525244191/d270615d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-244191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer